Cargando…
Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis
BACKGROUND: Characterization of the tumor microenvironment is helpful to understand the tumor immune environment of lung cancer and help predict the prognosis. METHODS: First, immune subtypes were identified by consensus subtype among lung squamous carcinoma (LUSC) patients. Immune cell infiltration...
Autores principales: | Yin, Liyuan, Zhang, Wen, Pu, Dan, Zhai, Xiaoqian, Lin, Yiyun, Wu, Qiang, Chang, Tangel, Hu, Jia, Li, Yan, Zhou, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847157/ https://www.ncbi.nlm.nih.gov/pubmed/35186710 http://dx.doi.org/10.3389/fonc.2021.778549 |
Ejemplares similares
-
Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy
por: Zhai, Xiaoqian, et al.
Publicado: (2022) -
Gas6/AXL pathway: immunological landscape and therapeutic potential
por: Zhai, Xiaoqian, et al.
Publicado: (2023) -
Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib
por: Zhai, Xiaoqian, et al.
Publicado: (2023) -
Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma
por: Li, Rui, et al.
Publicado: (2020) -
Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
por: Pu, Dan, et al.
Publicado: (2021)